TORONTO, March 26, 2024 /PRNewswire/ – Sun Life Financial Inc. (TSX: SLF) (NYSE: SLF) (the “Company”) today announced that its Annual Meeting of shareholders and the Annual Meeting of voting policyholders of Sun Life Assurance Company of Canada scheduled for Thursday, May 9, 2024 will be held both via live webcast online and in person. The… Continue reading Sun Life announces Annual Meetings of shareholders and voting policyholders and availability of 2023 Annual Report, 2024 Management Information Circular and 2024 Information for Voting Policyholders’ Booklet
Category: Newswire
Europe Recyclable Thermoset Market Analysis and Forecast, 2022-2023 and 2031: Opportunities in Replacing Virgin Materials with Recyclable Thermoset and Venturing into New End-User Applications
DUBLIN, March 26, 2024 /PRNewswire/ — The “Europe Recyclable Thermoset Market – Analysis and Forecast, 2022-2031” report has been added to ResearchAndMarkets.com’s offering. The Europe recyclable thermoset market is projected to reach $259.74 million by 2031 from $145.07 million in 2022, growing at a CAGR of 6.69% during the forecast period 2022-2031. The European recyclable thermoset market… Continue reading Europe Recyclable Thermoset Market Analysis and Forecast, 2022-2023 and 2031: Opportunities in Replacing Virgin Materials with Recyclable Thermoset and Venturing into New End-User Applications
PAVmed Provides Business Update and Fourth Quarter and Full Year 2023 Financial Results
Lucid’s quarterly revenue increased 33 percent sequentially Launched wholly-owned incubator, PMX, to complete development and commercialization of existing portfolio technologies Conference call and webcast to be held tomorrow, March 27th at 8:30 AM ET NEW YORK, March 26, 2024 /PRNewswire/ — PAVmed Inc. (Nasdaq: PAVM, PAVMZ) (“PAVmed” or the “Company”), a diversified commercial-stage medical technology company, operating… Continue reading PAVmed Provides Business Update and Fourth Quarter and Full Year 2023 Financial Results
ROSEN, SKILLED INVESTOR COUNSEL, Encourages LuxUrban Hotels, Inc. Investors with Losses in Excess of $100K to Secure Counsel Before Important Deadline in Securities Class Action – LUXH
NEW YORK, March 26, 2024 /PRNewswire/ — WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of LuxUrban Hotels, Inc. (NASDAQ: LUXH) between November 8, 2023 and February 2, 2024, both dates inclusive (the “Class Period”), of the important April 12, 2024 lead plaintiff deadline. SO WHAT: If you purchased LuxUrban securities… Continue reading ROSEN, SKILLED INVESTOR COUNSEL, Encourages LuxUrban Hotels, Inc. Investors with Losses in Excess of $100K to Secure Counsel Before Important Deadline in Securities Class Action – LUXH
DEADLINE ALERT: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Plug
NEW YORK, March 26, 2024 /PRNewswire/ — Faruqi & Faruqi, LLP, a leading national securities law firm, is investigating potential claims against Plug Power Inc. (“Plug” or the “Company”) (NASDAQ: PLUG) and reminds investors of the May 21, 2024 deadline to seek the role of lead plaintiff in a federal securities class action that has been… Continue reading DEADLINE ALERT: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Plug
TAKE ACTION: The M&A Class Action Firm Launches Legal Inquiry for the Merger – HMST, FREE, EVBG, INBX
NEW YORK, March 26, 2024 /PRNewswire/ — Monteverde & Associates PC (the “M&A Class Action Firm”), has recovered money for shareholders and is recognized as a Top 50 Firm in the 2018-2022 ISS Securities Class Action Services Report. We are headquartered at the Empire State Building in New York City and are now investigating: HomeStreet, Inc. (Nasdaq: HMST),… Continue reading TAKE ACTION: The M&A Class Action Firm Launches Legal Inquiry for the Merger – HMST, FREE, EVBG, INBX
Africa Insurance Market on the Rise: Projected Growth at 6.5% CAGR from 2023-2032 – Key Players Include African Life Assurance, The Liberty Holdings, Libya Insurance, MISR Insurance and Old Mutual
DUBLIN, March 26, 2024 /PRNewswire/ — The “Africa Insurance Market Report by Type (Life Insurance, Non-Life Insurance), and Country 2024-2032” report has been added to ResearchAndMarkets.com’s offering. The African insurance market size reached US$ 87.4 Billion in 2023 and is forecast to reach US$153.9 Billion by 2032, exhibiting a growth rate (CAGR) of 6.5% during 2023-2032. The… Continue reading Africa Insurance Market on the Rise: Projected Growth at 6.5% CAGR from 2023-2032 – Key Players Include African Life Assurance, The Liberty Holdings, Libya Insurance, MISR Insurance and Old Mutual
Natural Grocers® Announces Upcoming Relocation of Oklahoma City – North May Ave. Store, May 2nd, 2024
Natural Grocers’ good4u® Crew will kick off the Grand Relocation festivities at 8:15 AM with a $2,500 donation presentation to the Regional Food Bank of Oklahoma—its local food bank partner, followed by an official ribbon-cutting ceremony with the store manager, the store’s Nutritional Health Coach and additional community leaders. Doors will open at 8:27 AM with exciting giveaways, sweepstakes, sales and free… Continue reading Natural Grocers® Announces Upcoming Relocation of Oklahoma City – North May Ave. Store, May 2nd, 2024
World First Use of Lightpoint’s SENSEI® Drop-In Gamma Probe in Bladder Cancer Surgery Performed in Spain
LONDON, March 26, 2024 /PRNewswire/ — Lightpoint Surgical Limited (Lightpoint), an affiliate of Telix Pharmaceuticals Limited (ASX: TLX, Telix, the Company) today announces a world-first bladder cancer sentinel lymph node (SLN) procedure with SENSEI®, Telix’s miniature robotic-assisted gamma probe used to detect radiation in patients and guide surgery. The patient was operated on at Hospital del… Continue reading World First Use of Lightpoint’s SENSEI® Drop-In Gamma Probe in Bladder Cancer Surgery Performed in Spain
Bridge Biotherapeutics Announces a Research Collaboration with the University of Colorado School of Medicine to Explore Potential of BBT-877 for Immuno-Oncology
SEONGNAM, South Korea and AURORA, Colo., March 26, 2024 /PRNewswire/ — Bridge Biotherapeutics (KQ288330), a South Korean clinical-stage biotech company developing novel drugs for cancer, fibrosis, and inflammation, announced a research collaboration with Dr. Raul Torres’s Lab at the University of Colorado School of Medicine. The collaboration will focus on exploring the potential of BBT-877,… Continue reading Bridge Biotherapeutics Announces a Research Collaboration with the University of Colorado School of Medicine to Explore Potential of BBT-877 for Immuno-Oncology